Hard crowd to please, cast your mind back to when the share...

Hard crowd to please, cast your mind back to when the share price crashed to sub 30c due to woeful Elmo & co, Arrow Pharma acquisition, excessive losses to bad pharmacy accounts, silly credit terms to pharmacies and some other woeful expansions & acquistions. Change of management and fostering essentially a back to basics attitude, tightening terms for pharmacies, ditching poor brands/acquisitions, more efficiency and better overall management all in the light of price disclosure pressure for PBS meds and loss of turnover from loss of Pfizer products. Sigma has emerged out of the ashes as a more resilient organisation than 5 years ago with a better attitude to it's bottom line.
I would be surprised if SIP doesn't snuggle and settle over the $1 - $1.20 mark.